Abstract
The pathogenesis of corticotroph adenomas is unknown. In a recent study accumulation of p53 protein was detected by immunohistochemistry in a substantial proportion of pituitary corticotroph adenomas, and it has been suggested that it may be causally related to their development. However, other immunohistochemical studies have not confirmed the high incidence of p53 accumulation in this tumor type. Therefore, in the present study, p53 protein accumulation was re-examined in a series of 31 cases of corticotroph adenomas, using different sets of well validated anti-p53 antibodies. Furthermore, in view of the known association of p53 protein with apoptosis, and the known property of p53 to form complexes with heat shock proteins (HSPs), the relationship of p53 accumulation in corticotroph adenomas with apoptosis and HSP-70 was also investigated. Tumor samples staining positively for ACTH from patients with Cushing's disease or Nelson's syndrome were studied. Accumulation of p53 protein was tested by the standard ABC method using two different sets of clone Pab1801 and DO-7 monoclonal antibodies, applied after incubation of sections in a microwave oven. Using the DO-7 antibody, nuclear accumulation of p53 protein was detected in a total of 15 cases, with cytoplasmic staining observed in only 3 tumors. In contrast, using the Pab1801 antibody nuclear staining was observed in only 5 adenomas, with 11 adenomas demonstrating focal cytoplasmic immunoreactivity. Parallel sections of all corticotroph tumors demonstrating cytoplasmic accumulation of p53 protein were tested for the immunohistochemical presence of heat shock protein HSP-70. A striking similar distribution pattern of these two proteins was observed. Apoptosis, identified by the in situ end labeling technique, was detected in a total of 15 out of 28 corticotroph adenomas tested. Calculation of the apoptotic labeling index (ALI) by image analysis showed a significantly lower ALI in those corticotroph adenomas demonstrating nuclear p53 accumulation compared to those with no nuclear p53 immunostaining (p<0.05). There was no significant difference in the ALI between cytoplasmic p53 positive and negative tumors. It is concluded that depending on the antibody used there is a significant variation of p53 protein detection in corticotroph adenomas. Overall, a significant proportion of corticotroph adenomas studied expressed the p53 protein, which depending on the antibody used, was located either in the nucleus and/or the cytoplasm of tumorous corticotroph cells. Cytoplasmic accumulation of p53, as shown by our colocalization studies with HSP-70, may be due to p53/HSP-70 complex formation. Although such a complex-mediated cytoplasmic exclusion of p53 has no significant effect on apoptosis, nuclear accumulation of p53 protein is associated with a significantly lower apoptotic index indicating a failure of p53 protein to exert its apoptotic action in at least a subset of this tumor type.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Pei L, Melmed S, Scheithauer BW, Kovacs K, Prager D. H-ras mutations in human pituitary carcinoma metastases. J Clin Endocrinol Metab 1994;78:842–846.
Li FP, Fraumeni JF. Prospective study of a cancer family syndrome. JAMA 1982;247:2692–2694.
Varley JM, Evans DGR, Birch JM. Li-Fraumeni syndrome -Amolecular and clinical review. Br J Cancer 1997;76:1–14.
Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991;253:49–53.
Levin AJ, Momand J, Finaly CA. The p53 tumor suppressor gene. Nature 1991;351:453–356.
Herman V, Drazin NZ, Gonsky R, Melmed S. Molecular screening of pituitary adenomas and rearrangements. J Clin Endocrinol Metab 1993;77:50–55.
Shaw PH. The role of p53 in cell cycle regulation. Path Res Pract 1996;192:669–675.
Buckley N, Bates AS, Broome JC, Strange RC, Perrett CW, Burke CW, Clayton RN. p53 protein accumulates in Cushing' adenomas and invasive non-functioning adenomas. J Clin Endocrinol Metab 1994;79:1513–1516.
Thapar K, Scheithauer BW, Kovacs K, Pernicone PJ, Laws ER Jr. p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions. Neurosurgery 1996;38:765–771.
Pinhashi-Kimhi O, Michalovitz D, Ben-Zeev A, Oren M. Specific interaction between the p53 cellular tumor antigen and major heat shock proteins. Nature 1986;320:182–185.
Koskinen PJ, Sistonen L, Evan G, Morimoto R, Alitalo K. Nuclear organization of cellular and viral myc proteins with HSP70 in myc-overexpressing cells. J Virol 1991;65:842–851.
Lehman TA, Bennett WP, Metcalf RA Welch JA, Ecker J, Modali RV, Ullrich S, Romano JW, Appella E, Testa JR, Gerwin BI, Harris CC. p53 mutations, ras mutations and p53-heat-shock 70 protein complexes in human lung carcinoma cell lines. Cancer Res 1991;51:4090–4096.
Kontogeorgos G, Stefaneanu L, Kovacs K. Stress-response proteins in human pituitary adenomas: Expression of heatshock protein 72. Endocrine 1997a:25–29.
Kontogeorgos G, Sambaziotis D, Karameris G, Piaditis G. Apoptosis in humanpituitary adenomas: amorphologic study and in situ-end labeling study.ModPathol 1997b;10:921–926.
Vojtesek B, Bartek J, Midgley CA, Varley DP. An immunohistochemical analysis of the human nuclear phospho protein p53. J Immunol Meth 1992;151:237–244.
Green VL, White MC, Hipkin LJ, Jeffreys RV, Foy PM, Atkin SL. Apoptosis and p53 suppressor gene protein expression in human anterior pituitary adenomas. Eur J Endocrinol 1997;136:382–387.
Schlamp CL, Poulsen GL, Nork TM, Nickells RW. Nuclear exclusion of wild-type p53 in immortalized hunan retinoblastoma cells. J Natl Cancer Inst 1997;89:1530–1536.
Finaly CA, Hinds PW, Tan T-H, Eliyahu D, Oren M, Levine AJ. Activating mutations for transformation by p53 produce a gene product that forms an hsp 70-p53 complex with an altered half-life. Mol Cell Biol 1988;8:531–539.
Levy A, Hall Yeudall WA, Lightman SL. p53 gene mutations in pituitary adenomas: Rare events. Clin Endocrinol (Oxf) 1994;41:809–814.
Batiffora H. p53 immunoreactivity: A word of caution. Hum Pathol 1994;25:435–436.
Bukulmez G, Kaplan L, Delios L, Gutierrez LS. Discordant p53 overexpression on frozen and paraf~n sections in breast carcinomas. Potential false positive results with antigen retrieval methods (abstract). Mod Pathol 1997;1058, 180A
Goldman SC, Chen C-Y, Lansing TJ, Gilmer TM, Kastan MB. The p53 signal transduction pathway is intact in human neuroblastoma despite cytoplasmic localization.AmJ Pathol 1997;148:1381–1385.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kontogeorgos, G., Kapranos, N., Thodou, E. et al. Immunocytochemical Accumulation of p53 in Corticotroph Adenomas: Relationship with Heat Shock Proteins and Apoptosis. Pituitary 1, 207–212 (1999). https://doi.org/10.1023/A:1009929704018
Issue Date:
DOI: https://doi.org/10.1023/A:1009929704018